Skip to Main Content

Author Details

Catherine P Langford
University of Alabama at Birmingham
2005
22
15
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35852875An in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinases.JCI Insight2022
35852875An in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinases.JCI Insight2022
34702850A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas.Sci Rep2021
34702850A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas.Sci Rep2021
35342877Evaluation of immunologic parameters in canine glioma patients treated with an oncolytic herpes virus.J Transl Genet Genom2021
35342877Evaluation of immunologic parameters in canine glioma patients treated with an oncolytic herpes virus.J Transl Genet Genom2021
30942445Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma.Int J Oncol2019
30942445Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma.Int J Oncol2019
29849102Combinatorial Drug Testing in 3D Microtumors Derived from GBM Patient-Derived Xenografts Reveals Cytotoxic Synergy in Pharmacokinomics-informed Pathway Interactions.Sci Rep2018
30224769Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression.Sci Rep2018
29849102Combinatorial Drug Testing in 3D Microtumors Derived from GBM Patient-Derived Xenografts Reveals Cytotoxic Synergy in Pharmacokinomics-informed Pathway Interactions.Sci Rep2018
30224769Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression.Sci Rep2018
28455961Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit.Oncotarget2017
28455961Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit.Oncotarget2017
26188016Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses.Neuro Oncol2016
27341166Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing.J Vis Exp2016
26188016Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses.Neuro Oncol2016
27610392Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma.J Immunol Res2016
27784340IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice.J Ovarian Res2016
27610392Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma.J Immunol Res2016
27784340IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice.J Ovarian Res2016
27341166Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing.J Vis Exp2016
25427614γ⿁34.5-deleted HSV-1-expressing human cytomegalovirus IRS1 gene kills human glioblastoma cells as efficiently as wild-type HSV-1 in normoxia or hypoxia.Gene Ther2015
25832732γ⿁34.5-deleted HSV-1-expressing human cytomegalovirus IRS1 gene kills human glioblastoma cells as efficiently as wild-type HSV-1 in normoxia or hypoxia.Gene Ther2015
25427614γ⿁34.5-deleted HSV-1-expressing human cytomegalovirus IRS1 gene kills human glioblastoma cells as efficiently as wild-type HSV-1 in normoxia or hypoxia.Gene Ther2015
25955158Dynamics of Circulating γδ T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma.PLoS One2015
26167936ROCK Inhibition Facilitates In Vitro Expansion of Glioblastoma Stem-Like Cells.PLoS One2015
26167936ROCK Inhibition Facilitates In Vitro Expansion of Glioblastoma Stem-Like Cells.PLoS One2015
25832732γ⿁34.5-deleted HSV-1-expressing human cytomegalovirus IRS1 gene kills human glioblastoma cells as efficiently as wild-type HSV-1 in normoxia or hypoxia.Gene Ther2015
25955158Dynamics of Circulating γδ T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma.PLoS One2015
24819299The role of Src family kinases in growth and migration of glioma stem cells.Int J Oncol2014
24819299The role of Src family kinases in growth and migration of glioma stem cells.Int J Oncol2014
20532954Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme.J Neurooncol2011
21498545The RNA-binding protein HuR promotes glioma growth and treatment resistance.Mol Cancer Res2011
20532954Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme.J Neurooncol2011
22027691Therapeutic potential of AZD1480 for the treatment of human glioblastoma.Mol Cancer Ther2011
22027691Therapeutic potential of AZD1480 for the treatment of human glioblastoma.Mol Cancer Ther2011
21498545The RNA-binding protein HuR promotes glioma growth and treatment resistance.Mol Cancer Res2011
19235262High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI.Magn Reson Med2009
19521665Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111.J Neurooncol2009
19235262High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI.Magn Reson Med2009
19521665Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111.J Neurooncol2009
16053696Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model.Neuro Oncol2005
16053696Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model.Neuro Oncol2005
  • 1 - 44 of 44

Recommended Authors

Chirayu Chokshi
McMaster University
Career Start Year 2015
Number of shared co-authors 0
Maxim Sidorov
California Pacific Medical Center Research Institute
Career Start Year 2009
Number of shared co-authors 0
Tobias Weiss
Westlake University
Career Start Year 2009
Number of shared co-authors 0
Chitra Venugopal
McMaster Stem Cell and Cancer Research Institute
Career Start Year 2006
Number of shared co-authors 0
Nicholas Butowski
University of California san francisco
Career Start Year 2005
Number of shared co-authors 0
Adam M Sonabend
Northwestern University
Career Start Year 2005
Number of shared co-authors 0
Verlene Henry
The MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Gavin P Dunn
Washington University School of Medicine
Career Start Year 2002
Number of shared co-authors 0
Sheila K Singh
McMaster University
Career Start Year 2001
Number of shared co-authors 0
Jeongwu Lee
Lerner Research Institute, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 2
Marta M Alonso
CIMA-Universidad de Navarra
Career Start Year 2001
Number of shared co-authors 0
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 1998
Number of shared co-authors 0
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Career Start Year 1996
Number of shared co-authors 3
Vinay K Puduvalli
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Career Start Year 1996
Number of shared co-authors 1
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 3
Paul S Mischel
Stanford University
Career Start Year 1994
Number of shared co-authors 0
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Career Start Year 1992
Number of shared co-authors 2
Frank B Furnari
University of California San Diego
Career Start Year 1992
Number of shared co-authors 1
Donald M O'Rourke
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Career Start Year 1991
Number of shared co-authors 0
Howard Colman
Huntsman Cancer Institute, University of Utah
Career Start Year 1990
Number of shared co-authors 1
Candelaria Gomez-Manzano
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 1
Howard A Fine
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 0
Amy B Heimberger
Northwestern University Feinberg School of Medicine
Career Start Year 1988
Number of shared co-authors 0
Motoo Nagane
Kyorin University Faculty of Medicine
Career Start Year 1988
Number of shared co-authors 0
Michael Weller
University Hospital and University of Zurich
Career Start Year 1987
Number of shared co-authors 1
William A Weiss
University of California san francisco
Career Start Year 1985
Number of shared co-authors 1
Erwin G Van Meir
Heersink School of Medicine, University of Alabama at Birmingham
Career Start Year 1984
Number of shared co-authors 3
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1984
Number of shared co-authors 1
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Career Start Year 1974
Number of shared co-authors 1

Collaborators

George Yancey Gillespie
Heersink School of Medicine, The University of Alabama at Birmingham
Co-authored papers 20
Joshua C Anderson
University of Alabama at Birmingham
Co-authored papers 4
Christopher D Willey
University of Alabama at Birmingham
Co-authored papers 4
Nicholas Eustace
City of Hope National Medical Center
Co-authored papers 3
Hui Xu
Co-authored papers 2
Eddy S Yang
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Co-authored papers 2
Anita B Hjelmeland
University of Alabama at Birmingham
Co-authored papers 2
David F Bauer
9Baylor College of Medicine
Co-authored papers 1
Kevin J Lee
Mayo Clinic
Co-authored papers 1
Fady M Mikhail
University of Alabama at Birmingham
Co-authored papers 1
Xianwei Cui
Nanjing Medical University
Co-authored papers 1
David K Crossman
University of Alabama at Birmingham
Co-authored papers 1
Christian T Stackhouse
Co-authored papers 1
Zongliang Yue
University of Alabama at Birmingham, USA Informatics Institute
Co-authored papers 1
Dongquan Chen
University of Alabama at Birmingham
Co-authored papers 1
Jake Y Chen
Co-authored papers 1
Christopher Ryan Miller
University of Illinois at Urbana-Champaign
Co-authored papers 1
Thanh Nguyen
University of Alabama at Birmingham
Co-authored papers 1
James R Rowland
The Ohio State University
Co-authored papers 1
Jake Y. Chen (CM4AI)
University of Alabama at Birmingham
Co-authored papers 1
Jelai Wang
University of Alabama at Birmingham
Co-authored papers 1
Ryan E Bash
University of Alabama School of Medicine
Co-authored papers 1
Chuan Xing
The University of Alabama at Birmingham, Hazelrig Salter Radiation Oncology Center
Co-authored papers 1
Hasan Alrefai
Co-authored papers 1
Release 1.2